Yearly Archives: 2022

Class 4 Medicines Defect Information: Atorvastatin 4mg/ml Oral Suspension & Sildenafil 10mg/ml Oral Suspension (Rosemont Pharmaceuticals Ltd) Drug alert number: EL (22)A/39 Date issued: 14 September 2022 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Atorvastatin 4mg/ml Oral Suspension PL 00427/0256 Batch Number Expiry Date [...]

The post MHRA Class 4 Medicines Defect Information: Atorvastatin 4mg/ml Oral Suspension & Sildenafil 10mg/ml Oral Suspension (Rosemont Pharmaceuticals Ltd) appeared first on PSNC Website.

Community pharmacy contractors can now access a recording of PSNC’s recent webinar on price concessions. Around 750 people registered for last week’s webinar which aimed to provide contractors with a better understanding of how the price concession system operates and PSNC’s work in this area. Nine in ten said they would recommend the webinar to [...]

The post Price Concessions Webinar now available on-demand appeared first on PSNC Website.

Following the sad death of Her Majesty Queen Elizabeth II, her state funeral is on Monday 19th September. To help the nation pay its respects, the day has been declared a Bank Holiday. NHS England has discussed with PSNC how this will impact community pharmacy and is in the process of sending a letter to [...]

The post Death of HM the Queen: Bank Holiday announcement appeared first on PSNC Website.

Note, this story was originally published on 12th September 2022. Following the announcement of a new discount deduction system, PSNC has developed a webtool to help community pharmacy contractors estimate the impact on their payments. The calculator aims to illustrate the changes to discount deduction that a pharmacy could experience during the transition to the [...]

The post Discount Deduction: PSNC launches impact calculator tool (updated) appeared first on PSNC Website.

Class 4 Medicines Defect Information: Bezalip Mono 400mg Tablets (Quadrant Pharmaceuticals Limited) Drug alert number: EL (22)A/38 Date issued: 12 September 2022 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Bezalip Mono 400mg Tablets (Quadrant Pharmaceuticals Limited) PLPI 20774/0036 Batch Number Expiry Date Pack Size [...]

The post MHRA Class 4 Medicines Defect Information: Bezalip Mono 400mg Tablets (Quadrant Pharmaceuticals Limited) appeared first on PSNC Website.